China Pharma Holdings (CPHI) Long-Term Debt Issuances (2016 - 2025)
Historic Long-Term Debt Issuances for China Pharma Holdings (CPHI) over the last 14 years, with Q3 2025 value amounting to -$44176.0.
- China Pharma Holdings' Long-Term Debt Issuances fell 74556.48% to -$44176.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $260299.0, marking a year-over-year increase of 84667.95%. This contributed to the annual value of $27353.0 for FY2024, which is 1052.92% down from last year.
- China Pharma Holdings' Long-Term Debt Issuances amounted to -$44176.0 in Q3 2025, which was down 74556.48% from $290886.0 recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Long-Term Debt Issuances ranged from a high of $932114.0 in Q3 2022 and a low of -$3.7 million during Q4 2021
- Moreover, its 5-year median value for Long-Term Debt Issuances was $6852.0 (2024), whereas its average is -$129569.0.
- In the last 5 years, China Pharma Holdings' Long-Term Debt Issuances crashed by 835290.29% in 2021 and then surged by 414527.15% in 2025.
- China Pharma Holdings' Long-Term Debt Issuances (Quarter) stood at -$3.7 million in 2021, then soared by 100.19% to $6848.0 in 2022, then increased by 1.42% to $6945.0 in 2023, then dropped by 2.06% to $6802.0 in 2024, then plummeted by 749.46% to -$44176.0 in 2025.
- Its last three reported values are -$44176.0 in Q3 2025, $290886.0 for Q2 2025, and $6787.0 during Q1 2025.